J4 ›› 2010, Vol. 36 ›› Issue (1): 183-187.

• 基础研究 • 上一篇    下一篇

帕瑞昔布钠用于急性轻型颅脑创伤术后镇痛的效果评价

李艳伟1|夏天1|刘暌2|闫华2|孟春3   

  1. 1. 天津医科大学第二医院肾内科|天津 300211;2. 天津市环湖医院神经外科研究所|天津 300060;3. 天津市环湖医院麻醉科|天津 300060
  • 收稿日期:2009-08-14 出版日期:2010-01-28 发布日期:2010-01-28
  • 通讯作者: 夏 天(Tel:022-81985328,E-mail:yan_v2008@163.com) E-mail:yan_v2008@163.com
  • 作者简介:李艳伟(1978-)|女|天津市人|主治医师|主要从事药物治疗不良反应及肾保护研究。
  • 基金资助:

    天津市科委科技支撑计划项目资助课题(08ZCGYSF01600)

Evaluation of curative effect of postoperative analgesia of parecoxi-sodium on patients with acute slightly head injury

 LI Yan-Wei1, XIA Tian1, LIU Kui2, YAN Hua2, MENG Chun3   

  1. 1. Department of Nephrology,Second Hospital,Tianjin Medical University,Tianjin 300211,China;2.Institute of Neurosurgery, Tianjin Huanhu Hospital,Tianjin 300060,China;3. Department of Anesthesiology, Tianjin Huanhu Hospital,Tianjin 300060,China
  • Received:2009-08-14 Online:2010-01-28 Published:2010-01-28

摘要:

目的:评价静脉注射帕瑞昔布钠(parecoxi-sodium)用于急性轻型颅脑创伤术后镇痛的临床效果和安全性。  方法:ASAⅠ-Ⅱ、年龄18~78岁、拟行急性轻型颅脑创伤手术患者60例,随机均分为2组(每组30例):帕瑞昔布钠组患者术后静脉注射帕瑞昔布钠40 mg,对照组患者静脉注射等量生理盐水,观察术后24 h盐酸曲马多的用量、术后镇痛病例数、术后的疼痛强度(VAS评分)、患者对镇痛的满意度、不良反应以及用药前后凝血功能的变化。  结果:与对照组比较,帕瑞昔布钠组术后24 h盐酸曲马多用量减少(P<0.05),术后镇痛病例数减少(P<0.05),术后VAS评分降低(P<0.05),术后24 h患者对镇痛满意度提高(P<0.05),不良反应发生率降低(P<0.05),但术后2组凝血指标差异无显著性(P>0.05)。  结论:急性轻型颅脑创伤术后静脉给予帕瑞昔布钠40 mg可安全地减少术后曲马多用量,提高患者术后镇痛质量。

关键词: R651.15

Abstract:

Abstract:Objective To investigate the effectiveness and safety of administration of parecoxib-sodium on the patients with acute slightly  head injury for postoperative analgesia.  Methods  60 patients with slightly head injury,ASAⅠorⅡ,aged 18-78 years,scheduled for acute neurosurgical operation were randomly divided into two groups(n=30):parecoxib-sodium group received intravenous parecoxib -sodium 40 mg immediately after operation and control group received intravenous equivalence saline at the same time.The tramadol hydrochloride consumption at 24 h after operation,the number of unsatisfied demand and the number of successfully delivered doses were observed,and the intensity of pain was measured using VAS scores;the adverse effects,the patients’ global evaluation of the postoperative analgesia and blood coagulation function before and after administration were recorded and compared between two groups. Results The tramadol hydrochloride consumption at 24 h after operation,the percentage of the patients who needed postoperative analgesia,and the VAS scores of the patients after operation in parecoxib-sodium group were significantly lower than those in control group(P<0.05).At the same time,the percentage of the patients in parecoxib-sodium group who considered the postoperative analgesia satisfied was higher than that in control group(P<0.05). And the percentage of patients’ adverse effects in parecoxib-sodium group was lower than that in control group(P<0.05).There was no significant difference in coagulation between parecoxib-sodium group and control group(P>0.05). Conclusion Parecoxib 40 mg given in vein after neurosurgical operation can reduce the tramadol hydrochloride consumption and improve postoperative analgesia in patients with acute slightly head injury.

Key words: parecoxib-sodium;acute slightly head injury;tramadol hydrochloride, analgesia;blood clotting function